Novel use of zolpidem in cerebellar mutism syndrome

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 2, 2011, Pages 148-149

  Shyu, Charles ^a   Burke, Kelly ^b   Souweidane, Mark M ^b,c   Dunkel, Ira J ^a   Gilheeney, Stephen W ^a   Gershon, Timothy ^d   Khakoo, Yasmin ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cerebellar mutism syndrome; posterior fossa syndrome; zolpidem

Indexed keywords

ZOLPIDEM;

AROUSAL; ARTICLE; ATAXIA; BEDTIME DOSAGE; BRAIN SURGERY; CASE REPORT; CEREBELLAR MUTISM SYNDROME; CHILD; DISEASE SEVERITY; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; LEFT HEMISPHERE; MEDULLOBLASTOMA; MENTAL INSTABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT RESPONSE;

CEREBELLAR DISEASES; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; FEMALE; GABA-A RECEPTOR AGONISTS; HUMANS; MEDULLOBLASTOMA; MUTISM; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PYRIDINES;

EID: 79952194981     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182053a1a     Document Type: Article

References (12)

1. Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: A prospective study by the Children's Oncology Group. J Neurosurg. 2006;105:444-451. (Pubitemid 44968374)
2. De Smet H, Baillieux H, Wackenier P, et al. Long-term cognitive deficits following posterior fossa tumor resection: A neuropsychological and functional neuroimaging follow-up study. Neuropsychology. 2009;23:694-704.
3. Brefel-Courbon C, Payoux P, Ory F, et al. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol. 2007;62:102-105. (Pubitemid 47240911)
4. Shames JL, Ring H. Transient reversal of anoxic brain injuryrelated minimally conscious state after zolpidem administration: A case report. Arch Phys Med Rehabil. 2008;89:386-388.
5. Thomas P, Rascle C, Mastain B, et al. Test for catatonia with zolpidem. Lancet. 1997;349:702. (Pubitemid 27107757)
6. Blumer JL, Reed MD, Steinberg F, et al. Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties. Clin Pharmacol Ther. 2008;83:551-558. (Pubitemid 351417057)
7. Morris EB, Phillips NS, Laningham FH, et al. Proximal dentatothalamocortical tract involvement in posterior fossa syndrome. Brain. 2009;132:3087-3095.
8. Ozgur BM, Berberian J, Aryan HE, et al. The pathophysiologic mechanism of cerebellar mutism. Surg Neurol. 2006;66: 18-25.
9. Miller NG, Reddick WE, Kocak M, et al. Cerebellocerebral diaschisis is the likely mechanism of postsurgical posterior fossa syndrome in pediatric patients with midline cerebellar tumors. AJNR Am J Neuroradiol. 2010;31:288-294.
10. Schiff ND, Posner JB. Another "Awakenings." Ann Neurol. 2007;62:5-7.
11. Caner H, Altinors N, Benli S, et al. Akinetic mutism after fourth ventricle choroid plexus papilloma: Treatment with a dopamine agonist. Surg Neurol. 1999;51:181-184. (Pubitemid 29095858)
12. Adachi J, Nishikawa R, Hirose T, et al. Mixed neuronal-glial tumor of the fourth ventricle and successful treatment of postoperative mutism with bromocriptine: Case report. Surg Neurol. 2004;63:375-379. (Pubitemid 40444709)